Ng George K

Ng George K is listed in filings as Chief Executive Officer at Processa Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including purchase activity. Recent filings connect the profile to Processa Pharmaceuticals, Inc. (PCSA) and TuHURA Biosciences, Inc. - Common Stock (HURA). The current snapshot covers public activity from Jan 6, 2025 to Jun 1, 2026. Reported amounts are shown as $5.5K to $201.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.